245 related articles for article (PubMed ID: 28431968)
21. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Scutt A; Williamson EM
Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid signalling inhibits sarcoplasmic Ca
Oláh T; Bodnár D; Tóth A; Vincze J; Fodor J; Reischl B; Kovács A; Ruzsnavszky O; Dienes B; Szentesi P; Friedrich O; Csernoch L
J Physiol; 2016 Dec; 594(24):7381-7398. PubMed ID: 27641745
[TBL] [Abstract][Full Text] [Related]
24. L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.
Naderi N; Ahmad-Molaei L; Mazar-Atabaki A; Ronaghi A; Shirazi-zand Z; Motiei-Langroudi SM; Eslahkar S
Neurochem Res; 2012 Feb; 37(2):279-87. PubMed ID: 21928146
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
26. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
[TBL] [Abstract][Full Text] [Related]
27. L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons.
Hoddah H; Marcantoni A; Comunanza V; Carabelli V; Carbone E
Cell Calcium; 2009; 46(5-6):303-12. PubMed ID: 19818494
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.
Fernández-López D; Martínez-Orgado J; Nuñez E; Romero J; Lorenzo P; Moro MA; Lizasoain I
Pediatr Res; 2006 Aug; 60(2):169-73. PubMed ID: 16864698
[TBL] [Abstract][Full Text] [Related]
30. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
[TBL] [Abstract][Full Text] [Related]
31. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
Sterin-Borda L; Del Zar CF; Borda E
Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
[TBL] [Abstract][Full Text] [Related]
32. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
33. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
34. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids inhibit ATP-activated currents in rat trigeminal ganglionic neurons.
Shen JJ; Liu CJ; Li A; Hu XW; Lu YL; Chen L; Zhou Y; Liu LJ
Sheng Li Xue Bao; 2007 Dec; 59(6):745-52. PubMed ID: 18157466
[TBL] [Abstract][Full Text] [Related]
36. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
[TBL] [Abstract][Full Text] [Related]
37. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
38. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells.
Huang Z; Wang H; Wang J; Zhao M; Sun N; Sun F; Shen J; Zhang H; Xia K; Chen D; Gao M; Hammer RP; Liu Q; Xi Z; Fan X; Wu J
Sci Rep; 2016 Jul; 6():29757. PubMed ID: 27432473
[TBL] [Abstract][Full Text] [Related]
40. Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear.
Bisby MA; Richardson R; Baker KD
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109834. PubMed ID: 31830508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
